Clinical trial
A randomized, double-blind, placebocontrolled, flexible-dose, parallel-group, Study of Lurasidone adjunctive to Lithium or Divalproex for the prevention of recurrence in subjects with bipolar I disorder
To evaluate the efficacy and safety of lurasidone (in combination with lithium or divalproex) for the maintenance treatment of bipolar I disorder in subjects with or without rapid cycling and/or psychotic features.
Category | Value |
---|---|
Study start date | 2011-08-31 |